TTP is recognized as a tumor‐suppressive protein based on numerous studies demonstrating its capacity to reduce the expression of genes linked to cancer progression, many of which have specifically documented a decrease in the expression of TTP proteins in diverse cancer types (Saini et al., 2020). The gene discussed is ZFP36; the disease is neoplasm.